These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 19794916)

  • 21. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics.
    Kim DK; Park J; Han D; Yang J; Kim A; Woo J; Kim Y; Mook-Jung I
    Mol Neurodegener; 2018 Jan; 13(1):2. PubMed ID: 29338754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The molecular bases of Alzheimer's disease and other neurodegenerative disorders.
    Maccioni RB; Muñoz JP; Barbeito L
    Arch Med Res; 2001; 32(5):367-81. PubMed ID: 11578751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modeling Alzheimer's disease in transgenic mice: effect of age and of presenilin1 on amyloid biochemistry and pathology in APP/London mice.
    Dewachter I; van Dorpe J; Spittaels K; Tesseur I; Van Den Haute C; Moechars D; Van Leuven F
    Exp Gerontol; 2000 Sep; 35(6-7):831-41. PubMed ID: 11053674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Caspase activation precedes and leads to tangles.
    de Calignon A; Fox LM; Pitstick R; Carlson GA; Bacskai BJ; Spires-Jones TL; Hyman BT
    Nature; 2010 Apr; 464(7292):1201-4. PubMed ID: 20357768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased misfolding and truncation of tau in APP/PS1/tau transgenic mice compared to mutant tau mice.
    Héraud C; Goufak D; Ando K; Leroy K; Suain V; Yilmaz Z; De Decker R; Authelet M; Laporte V; Octave JN; Brion JP
    Neurobiol Dis; 2014 Feb; 62():100-12. PubMed ID: 24076100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model.
    Helboe L; Egebjerg J; Barkholt P; Volbracht C
    Brain Res; 2017 Jun; 1665():22-35. PubMed ID: 28411086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transgenic mouse models for Alzheimer's disease: the role of GSK-3B in combined amyloid and tau-pathology.
    Muyllaert D; Terwel D; Borghgraef P; Devijver H; Dewachter I; Van Leuven F
    Rev Neurol (Paris); 2006 Oct; 162(10):903-7. PubMed ID: 17028556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of tau pathology by intracerebral infusion of amyloid-beta -containing brain extract and by amyloid-beta deposition in APP x Tau transgenic mice.
    Bolmont T; Clavaguera F; Meyer-Luehmann M; Herzig MC; Radde R; Staufenbiel M; Lewis J; Hutton M; Tolnay M; Jucker M
    Am J Pathol; 2007 Dec; 171(6):2012-20. PubMed ID: 18055549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Focal expression of adeno-associated viral-mutant tau induces widespread impairment in an APP mouse model.
    Dassie E; Andrews MR; Bensadoun JC; Cacquevel M; Schneider BL; Aebischer P; Wouters FS; Richardson JC; Hussain I; Howlett DR; Spillantini MG; Fawcett JW
    Neurobiol Aging; 2013 May; 34(5):1355-68. PubMed ID: 23273572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distribution of spleen tyrosine kinase and tau phosphorylated at tyrosine 18 in a mouse model of tauopathy and in the human hippocampus.
    Köhler C; Fuhr V; Dinekov M
    Brain Res; 2017 Dec; 1677():1-13. PubMed ID: 28919467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amyloid plaque and neurofibrillary tangle pathology in a regulatable mouse model of Alzheimer's disease.
    Paulson JB; Ramsden M; Forster C; Sherman MA; McGowan E; Ashe KH
    Am J Pathol; 2008 Sep; 173(3):762-72. PubMed ID: 18669616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles.
    Wittmann CW; Wszolek MF; Shulman JM; Salvaterra PM; Lewis J; Hutton M; Feany MB
    Science; 2001 Jul; 293(5530):711-4. PubMed ID: 11408621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel human neuronal tau model exhibiting neurofibrillary tangles and transcellular propagation.
    Reilly P; Winston CN; Baron KR; Trejo M; Rockenstein EM; Akers JC; Kfoury N; Diamond M; Masliah E; Rissman RA; Yuan SH
    Neurobiol Dis; 2017 Oct; 106():222-234. PubMed ID: 28610892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stress kinases involved in tau phosphorylation in Alzheimer's disease, tauopathies and APP transgenic mice.
    Ferrer I
    Neurotox Res; 2004; 6(6):469-75. PubMed ID: 15658002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Divergent pathways mediate spine alterations and cell death induced by amyloid-beta, wild-type tau, and R406W tau.
    Tackenberg C; Brandt R
    J Neurosci; 2009 Nov; 29(46):14439-50. PubMed ID: 19923278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tau-amyloid interactions in the rTgTauEC model of early Alzheimer's disease suggest amyloid-induced disruption of axonal projections and exacerbated axonal pathology.
    Pooler AM; Polydoro M; Wegmann SK; Pitstick R; Kay KR; Sanchez L; Carlson GA; Gomez-Isla T; Albers MW; Spires-Jones TL; Hyman BT
    J Comp Neurol; 2013 Dec; 521(18):4236-48. PubMed ID: 23839581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Participation of Amyloid and Tau Protein in Post-Ischemic Neurodegeneration of the Hippocampus of a Nature Identical to Alzheimer's Disease.
    Pluta R; Ouyang L; Januszewski S; Li Y; Czuczwar SJ
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33671097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
    Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterisation of cytoskeletal abnormalities in mice transgenic for wild-type human tau and familial Alzheimer's disease mutants of APP and presenilin-1.
    Boutajangout A; Authelet M; Blanchard V; Touchet N; Tremp G; Pradier L; Brion JP
    Neurobiol Dis; 2004 Feb; 15(1):47-60. PubMed ID: 14751770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High copy wildtype human 1N4R tau expression promotes early pathological tauopathy accompanied by cognitive deficits without progressive neurofibrillary degeneration.
    Wheeler JM; McMillan PJ; Hawk M; Iba M; Robinson L; Xu GJ; Dombroski BA; Jeong D; Dichter MA; Juul H; Loomis E; Raskind M; Leverenz JB; Trojanowski JQ; Lee VM; Schellenberg GD; Kraemer BC
    Acta Neuropathol Commun; 2015 Jun; 3():33. PubMed ID: 26041339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.